These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17992568)

  • 1. Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis.
    Ahmadi FA; Grammatopoulos TN; Poczobutt AM; Jones SM; Snell LD; Das M; Zawada WM
    Neurochem Res; 2008 May; 33(5):886-901. PubMed ID: 17992568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
    Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
    Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons.
    Ahmadi FA; Linseman DA; Grammatopoulos TN; Jones SM; Bouchard RJ; Freed CR; Heidenreich KA; Zawada WM
    J Neurochem; 2003 Nov; 87(4):914-21. PubMed ID: 14622122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
    Testa CM; Sherer TB; Greenamyre JT
    Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
    Jiang H; Ren Y; Zhao J; Feng J
    Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
    J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
    Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
    Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
    Grammatopoulos TN; Ahmadi F; Jones SM; Fariss MW; Weyhenmeyer JA; Zawada WM
    Brain Res; 2005 May; 1045(1-2):64-71. PubMed ID: 15910763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase.
    Wang Y; Liu D; Zhang H; Wang Y; Wei L; Liu Y; Liao J; Gao HM; Zhou H
    Toxicol Appl Pharmacol; 2017 May; 322():51-59. PubMed ID: 28283350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.
    Sarkar S; Gough B; Raymick J; Beaudoin MA; Ali SF; Virmani A; Binienda ZK
    Neurosci Lett; 2015 Oct; 606():53-9. PubMed ID: 26321151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism.
    Jiang Q; Yan Z; Feng J
    J Neurosci; 2006 Apr; 26(16):4318-28. PubMed ID: 16624952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.
    Buck SA; De Miranda BR; Logan RW; Fish KN; Greenamyre JT; Freyberg Z
    J Neurosci; 2021 Jun; 41(22):4937-4947. PubMed ID: 33893220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.
    Moon Y; Lee KH; Park JH; Geum D; Kim K
    J Neurochem; 2005 Jun; 93(5):1199-208. PubMed ID: 15934940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
    Zafar KS; Inayat-Hussain SH; Ross D
    J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of nerve growth factor on dopaminergic neurotoxin-induced apoptosis.
    Hirata Y; Meguro T; Kiuchi K
    J Neurochem; 2006 Oct; 99(2):416-25. PubMed ID: 17029596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture.
    Radad K; Gille G; Rausch WD
    Toxicol In Vitro; 2008 Feb; 22(1):68-74. PubMed ID: 17923380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
    Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
    Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
    Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
    Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
    Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.